Skip to main content
. Author manuscript; available in PMC: 2019 Aug 10.
Published in final edited form as: Nat Neurosci. 2016 Mar 14;19(4):571–577. doi: 10.1038/nn.4267

Figure 3.

Figure 3

A comparison of genome-wide de novo mutation rates in probands with ASD, DD, schizophrenia (SCZ) and controls. Rates are modeled using calibrated genome-wide mutation rates. Significant excess of de novo mutations when compared to the baseline model, *P < 4 × 10−3 (Bonferroni correction for 12 tests). Nominal significance can be inferred from the error bars (95% CI). Mis15, damaging missense; Syn, synonymous; see Online Methods.